Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;10(1):27-34.

Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care center

Jesse M Civan  1 , Victor Navarro  1 , Steven K Herrine  1 , Jeffrey M Riggio  1 , Paul Adams  1 , Simona Rossi  1
Affiliations

Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care center

Jesse M Civan et al. Gastroenterol Hepatol (N Y). 2014 Jan.

Abstract

Unintentional acetaminophen-induced hepatotoxicity has been increasingly recognized as a significant problem, prompting increased scrutiny and restrictions from the US Food and Drug Administration on products combining acetaminophen with narcotics. Patterns of acetaminophen use have not previously been reported in the hospitalized patient population, which may be especially vulnerable to liver injury. We aimed to quantify the frequency at which acetaminophen dosing exceeded the recommended maximum of 4 g/day in hospitalized patients. This was a retrospective, single-center, cohort study at a large tertiary care academic hospital. We queried our inpatient electronic medical record database to identify patients admitted between 2008 and 2010 who were receiving cumulative daily acetaminophen doses exceeding 4 g on at least 1 hospital day. Of 43,761 admissions involving acetaminophen administration, the recommended maximum cumulative daily dose of 4 g was exceeded in 1119 (2.6%) cases. Patients who were administered a larger number of acetaminophen-containing medications were more likely to receive doses in excess of the recommended maximum. Alanine aminotransferase (ALT) levels were checked within 14 days following acetaminophen exposure in excess of 4 g in 35 (3.1%) cases. Excessive acetaminophen dosing of hospitalized patients, who may be at increased risk for acetaminophen-induced hepatotoxicity, occurred in a minority of patients. The use of multiple acetaminophen-containing medication formulations contributed to excessive dosing. ALT level monitoring in this group was infrequent, precluding assessment of biochemical evidence of liver injury. This cohort of patients may represent an ideal population for further prospective study with more intensive and longer-term biochemical monitoring to assess for evidence of liver injury.

Keywords: Acetaminophen; drug safety; drug-induced liver injury; hepatotoxicity; hospitalized patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Acetaminophen use in the hospitalized population of a tertiary care center.
Figure 2
Figure 2
The maximum dose of acetaminophen in a single day during admissions involving doses in excess of 4 g.
Figure 3
Figure 3
The average duration of exposure to various threshold doses of acetaminophen for 1119 admissions involving administration of acetaminophen in excess of 4 g on at least 1 day.
Figure 4
Figure 4
The number of acetaminophen-containing medications in 1119 admissions involving administration of more than 4 g of acetaminophen on at least 1 day.
Figure 5
Figure 5
The frequency of ALT monitoring for 1119 admissions involving administration of more than 4 g of acetaminophen on at least 1 day.
See this image and copyright information in PMC

References

    1. [September 13, 2013]. http://www.fda.gov/Drugs/DrugSafety/ucm239821.htm FDA drug safety communication: prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure. FDA.
    1. [September 13, 2013]. http://www.fda.gov/downloads/AdvisoryCommit-tees/CommitteesMeetingMateri... Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) joint meeting of the Drug Safety and Risk Management Advisory Committee, Nonprescription Drugs Advisory Committee and the Anesthetic and Life Support Drugs Advisory Committee meeting to address the public health problem of liver injury related to the use of acetaminophen in both over-the-counter and prescription products. FDA.
    1. Amar PJ, Schiff ER. Acetaminophen safety and hepatotoxicity—where do we go from here? Expert Opin Drug Saf. 2007;6(4):34l–355. - PubMed
    1. Schilling A, Corey R, Leonard M, Eghtesad B. Acetaminophen: old drug, new warnings. Cleve Clin J Med. 2010;77(1):19–27. - PubMed
    1. Hawton K, Simkin S, Deeks J, et al. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ. 2004;329(7474):1076. - PMC - PubMed

LinkOut - more resources